City of Hope Reveals Vision for World-Class Cancer Care in Orange County

June 25, 2019 | City of Hope

City of Hope has accelerated its plans for a $1 billion comprehensive cancer campus in Orange County, bringing highly specialized cancer care, clinical trials, precision medicine and early detection to the nation’s sixth most populous county.

Continue Reading

Breakthrough drug shows results in lung, colon cancer

June 5, 2019 | Michael Easterling

A new drug being investigated by Marwan Fakih, M.D., professor in the Department of Medical Oncology & Therapeutics Research and medical director of the Judy & Bernard Briskin Center for Clinical Research, is "potentially practice-changing," Fakih said.

New drug shows strong results against stubborn mutation

June 5, 2019 | Michael Easterling

A new drug being investigated by Marwan Fakih, M.D., professor in the Department of Medical Oncology & Therapeutics Research and medical director of the Judy & Bernard Briskin Center for Clinical Research, is "potentially practice-changing," Fakih said.

Colorectal tumor biomarker may predict immunotherapy effectiveness

May 2, 2019 | Zen Vuong

The takeaway of foundational research by a City of Hope physician-scientist and his colleagues is that patients with metastatic colorectal cancer and a high tumor mutation score should consider immunotherapy as initial treatment.

Study finds cancer rate rising in millennials

March 6, 2019 | Dory Benford

A new study by the American Cancer Society finds rates of obesity-related cancers — including colorectal, endometrial, pancreatic, kidney, gallbladder and multiple myeloma — rising among young people.

Welcome to the Robotic Surgery Revolution

January 11, 2019 | Abe Rosenberg

In the three decades since robots first entered the operating room, these increasingly sophisticated machines have helped surgeons perform more than a million procedures, all over the human body.

New Immunotherapy for Colon Cancer Answers a Patient's Prayer

December 24, 2018 | Maxine Nunes

After a CAT scan found a suspicious spot, a colonoscopy showed that Quiana Godinez had colon cancer. Godinez was put on the breakthrough immunotherapy drug Keytruda (pembrolizumab), which had just received FDA approval for certain types of cancers, including hers.

New colorectal screening guidelines: What they mean for you

August 20, 2018 | Molly Peck

The American Cancer Society has changed the recommended age to start colorectal screening to 45, following a sustained increase in colorectal cancer in adults under 50.

Groundbreaking Heated Chemotherapy Treatment Gives Patient Renewed Hope

June 28, 2018 | Wayne Lewis

Suffering from abdominal pain that had grown severe over the course of a few days, Christopher Haskell visited his physician, a visit that ended up resulting in the discovery of a tumor growing in his appendix and colon. His City of Hope physician recommended an approach called HIPEC, short for “hyperthermic intraperitoneal chemotherapy.”